Form 4: Globus Medical Director Davidar David D Sells Shares Under 10b5-1 Plan

Globus Medical director Davidar David D sold a total of 39,990 Class A common shares across multiple transactions on November 21st and 22nd, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Davidar David D, a director at Globus Medical Inc., sold a total of 39,990 Class A common shares.
• The sales occurred on November 21st and 22nd, 2024.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan established on December 23, 2023.
• On November 21st, 13,234 shares were sold directly at $85 each, and 13,254 shares were sold indirectly through the Davidar Family Irrevocable Trust at $85 each.
• On November 22nd, 6,766 shares were sold directly at a weighted average price of $85.0037, and 6,746 shares were sold indirectly through the Davidar Family Irrevocable Trust at a weighted average price of $85.0037.
• The weighted average price for the November 22nd sales ranged from $85.00 to $85.10 per share.

Sentiment

Score: 5

Explanation: The document reflects a routine insider transaction under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Risks

• Large sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and these transactions are closely monitored by regulators and investors.

Comparison to Industry Standards

• Sales by insiders are a normal part of the market, and the use of a 10b5-1 plan is a common practice to avoid accusations of trading on inside information.
• The volume of shares sold is not unusual for a director's transactions, and the price is consistent with the market price at the time of the sales.
• Other companies in the medical device sector will have similar insider trading activity, and this transaction is not out of the ordinary.

Related Party Transactions

• Some shares were sold indirectly through the Davidar Family Irrevocable Trust, which is a related party transaction.

Stakeholder Impact

• The share sales may have a minor impact on the stock price, but the transactions were made under a pre-arranged plan, which should mitigate any negative perception.

Key Dates

Keywords

Globus Medical, insider trading, Form 4, Davidar David D, stock sale, 10b5-1 plan, share transaction, director